At Reckitt Benckiser, you have gradually taken positions of increasing responsibility over the last decade in Marketing. What would you highlight as the main specificities of…
In Conversation
The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General Manager of Ferring Turkey over those last…
Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how…
You have pharmaceuticals production in your background and have recently joined PharmaVision as General Manager. To what extent does this speak about the company’s direction? Could…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011,…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over…
